| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 109.51 | 3.6% | 4.6% |
| Total Income | 111.67 | 3.2% | 4.4% |
| Expenditure | 109.22 | 7.7% | 12.2% |
| PBT | 2.45 | 63.8% | 74.5% |
| Net Profit | 2.05 | 60.7% | 73.2% |
| OPM | 4.96% | 3.98pp | 6.29pp |
| NPM | 1.84% | 2.98pp | 5.32pp |
| EPS | 0.26 | 56.7% | 67.5% |
Margin Halved, Profit Crashed; Price Hikes Miss All Guidance
Radiant Cash delivered ₹109.5 Cr revenue and ₹2.1 Cr profit—a 73% collapse that smashes guidance targets. Management credits manpower cost spikes and delays the benefit of secured 12-15% price increases to Q4. The credibility gap is widening.
₹109.5 Cr
+4.6% YoY, +3.6% QoQ
₹2.1 Cr
-73.2% YoY, -60.7% QoQ
7.62%
Down from 15.2% YoY
1.8%
Down from 6.2% YoY
Radiant Cash delivered a quarter that squarely missed the bar set by its own guidance. Revenue growth of 4.6% year-over-year—and cash handled flat at ₹0.41 trillion—fell well short of the double-digit growth promised for FY27. More damaging, net profit crashed 73% while net margins compressed from 6.2% to 1.8%. EBITDA margin, the operational health metric that matters most for a cash-handling business, was halved from 15.2% to 7.62%. The culprit is unambiguous: manpower costs spiked on minimum wage hikes and armed guard shortages, consuming 70% of the total cost base. Management's answer is a price-hike strategy (12-15% increases secured industry-wide), but most of that benefit won't land until Q4.
Claims vs. Reality: Management's Guidance Scorecard
Double-digit revenue growth
+4.6% YoY; +3.6% QoQ
Missed—off pace by half
FY27 EBITDA margin 17-18% (contingent on price revision)
7.62% (Standalone); 6.8% (Consolidated)
Contradicted—margin halved, not supported
Acemoney to reach EBITDA breakeven in Q3
Still 'near breakeven' in Q2; turnaround lagging
Overstated—timeline slipping
Subsidiaries to turn profitable in H2 FY27
RVL growing 35% Q1-Q2 but not yet profitable; Acemoney not yet breakeven
Overstated—profitability push delayed
Direct client revenue targeting ~33% of revenue within 1-2 years
19.2% in Q2 (up from 15.7% YoY); slow progression
Supported but execution unproven at scale
What Changed on This Call
Three material shifts in the narrative:
Price hike strategy deployed: 12-15% increases secured from majority of clients (banks, retail). Banks from 1 Nov; retail from 1 Dec. Benefit accrual concentrated in Q4 FY27 and FY28.
Subsidiary profitability pushed back: Acemoney 'near breakeven,' not yet profitable. RVL ₹29.9 Cr revenue with 35% sequential growth but still in ramp phase. H2 FY27 target now uncertain.
Direct client base becoming core strategy: Shifting away from bank-dependent growth (80% of revenue, decelerating) to direct corporate clients (20% now, targeting 33%). Hiring sector specialists for retail, NBFCs, hospitals.
The Profitability Math: Price Hikes vs. Structural Costs
The debate on this call crystallized around one uncomfortable question: how does a company recovering from a 50% margin collapse get back to 20% profitability (IPO-level) with just a 12-15% price hike and unquantified tech cost cuts? Analyst Dilip pressed hard. Management's answer rested on three pillars: (1) price hikes of 12-15% now embedded in majority client contracts; (2) technology-driven cost optimization (unspecified); (3) subsidiary profitability contribution by H2 FY27 (timing uncertain). None of these levers was sized quantitatively. Col David Devasahayam defended the confidence: 'The worst is behind us.' Analysts Keshav Garg and Dilip remained unconvinced.
Significant increase in manpower costs triggered by revision in minimum wages and shortage of armed gunner and higher van costs resulted in lower profitability for this quarter.
This framing is honest but incomplete. Manpower costs are 70% of the cost base, and they're structural in India's cash management business—minimum wage hikes are state-mandated, guard shortages are acute in southern states, and competitors are facing the same wage inflation. The real question isn't whether price hikes are justified (they are—industry-wide) but whether the Q4 impact will be as 'steady and good' as management claimed. Most bank hikes came through on 1 Nov; retail slower. Gunman shortage remains acute.
Street Positioning: How the Market is Reading This
The stock has taken a beating. At ₹33.12, it sits 70.4% below its all-time high of ₹112.05, though it's recovered 7.85% from its 52-week low of ₹30.71. It trades above its 20-day moving average but well below both the 50-day (₹34.87) and 200-day (₹38.29) averages. RSI at 46.2 is neutral—no signs of capitulation, but no momentum either. Volume is normal.
The ownership picture is striking. FII ownership has collapsed to 0.17% (from 0.45% a year ago). DII is minimal at 0.66%. Promoters hold steady at 56.95%, unchanged quarter-over-quarter. This is a classic pattern of institutional retreat after an IPO disappointment. When the IPO promised ₹112 and the company misses guidance at ₹33, foreign and domestic institutions exit. The stock is left to retail, insiders, and those too illiquid to sell.
The market's own verdict, then, is clear: miss guidance hard enough, and no amount of 'confident' forward messaging holds the tape. The price action confirms the fundamental read—this quarter was a step backward, not a step toward IPO-level profitability.
Ranked Risks: What Should Concern a Holder Most
The Bull-Bear Ledger
12-15% price hikes are secured and embedded in majority of client contracts (banks from 1 Nov, retail from 1 Dec)
Direct client base strategy is sound: 19.2% revenue now, targeting 33% within 1-2 years, higher-margin recurring model
Subsidiary growth is real: RVL ₹29.9 Cr revenue, +35% Q1-Q2; Acemoney near breakeven with sound box and QR deployment scaling
Risk management culture is best-in-class: gross cash losses ₹1 million (0.0002% of ₹0.41 trillion handled)
Market penetration is low (~1.5%); long-term cash management growth structural in India
Guidance miss is severe and unexplained: Double-digit growth (delivered 4.6%), EBITDA 17-18% (delivered 7.62%), H2 subsidiary profitability (pushed back). No formal withdrawal, just reaffirmation.
Profit recovery path is unquantified: Tech cost cuts cited but not sized; unspecified as percentage of cost base or timeline
Manpower cost inflation is structural and ongoing: 70% of cost base affected; no visibility on wage easing
FII/DII ownership has collapsed: FII 0.17%, DII 0.66%. Institutions are exiting, leaving retail and illiquid holders
Price hike benefit is backloaded to Q4 and uncertain: Bank hikes from 1 Nov, retail from 1 Dec. No pre-announcement on realization % or competitive pressure
Stock is 70.4% below ATH and trading below 50-day and 200-day moving averages
The Debate
What to Watch Next
1 · Q4 FY27 price hike impact (early FY28 guidance)
The majority of 12-15% hikes take effect from 1 Nov (banks) and 1 Dec (retail). Q4 results (expected Feb/Mar 2027) or early FY28 guidance will show whether the benefit is as 'steady and good' as management claimed. Watch EBITDA margin recovery and NPM expansion. If they miss again, the credibility gap becomes a chasm.
2 · Acemoney and RVL profitability contribution
Management promised both to turn profitable in H2 FY27 (Q3 and Q4). Watch whether Acemoney reaches breakeven in Q3 (they said 'near' in Q2) and whether RVL crosses into positive PAT. If both slip into FY28, consolidated profit recovery is delayed again.
3 · Direct client base traction (% of revenue and growth rate)
The pivot away from bank-dependent growth (80%, decelerating) to direct clients (19.2% now, targeting 33%) is the medium-term story. Watch Q3-Q4 mix, whether direct client growth accelerates to 25%+ of revenue, and whether the margin uplift materializes. This is the 'prove-it' moment for management's strategic pivot.
The Honest Read
Radiant Cash is not in collapse—its business is sound, its risk management best-in-class, its market penetration low with structural tailwinds. But this quarter is a step backward, and management's reaffirmation of confidence without new numbers is not credible. They missed double-digit growth (delivered 4.6%), halved EBITDA margin (17-18% → 7.62%), and pushed back subsidiary profitability. The price hike strategy is real and will help, but it's backloaded to Q4 and not sufficient on its own to restore 20% profitability.
Recovery is possible—and priced into the stock (70% discount to ATH, well below 50-day/200-day averages). But it's not assured, and it's highly execution-dependent. The company needs: (1) price hikes to hold through Q4 without competitive response; (2) subsidiaries to actually turn profitable (not just 'near breakeven'); (3) direct client base to scale to 25%+ of revenue. Any slip on any of these axes extends the turnaround.
Verdict: Hold. Not a buy until management quantifies the path to 15%+ EBITDA margin and proves subsidiary profitability in Q3. Not a sell unless competitive undercutting emerges or wage inflation accelerates further. The stock reflects a deep turnaround. Watch Q4 results (early 2027) and FY28 guidance closely—that's when the story either resets or continues.
Margin collapsed, profit crashed; price hike bet misses guidance
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 5/10
Grade C
Missed FY27 double-digit growth guidance (delivered 4.6% YoY). EBITDA target halved (17-18% → 7.62%). Subsidiary profitability delayed.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 revenues +4.6% YoY and PAT -73.2% sharply miss prior guidance for double-digit growth and 17-18% EBITDA margin (delivered 7.62%). Management credits manpower cost surge and delays price-hike benefit to Q4; near-term margin recovery hinges on unquantified cost cuts and unproven subsidiary turnarounds. High execution risk.
₹109.5 Cr
Revenue · +4.6% YoY₹2.1 Cr
Reported PAT · −73.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Double-digit FY27 revenue growth expected
OVERSTATEDQ2 YoY +4.6%, QoQ +3.6%; well below double-digit
FY27 standalone EBITDA 17-18% margin
MISSStandalone EBITDA margin 7.62%; down from 15.2% prior year
Acemoney to reach EBITDA breakeven in Q3
OVERSTATEDAcemoney only 'near' breakeven in Q2; turnaround lagging guidance
Subsidiaries to turn profitable in H2 FY27
OVERSTATEDStill in loss-arrest phase; RVL showing 35% growth but Acemoney not yet profitable
Direct client business at 20%, growing to 33% of revenues
METDirect clients 19.2% in Q2; slow progression from 15.7% YoY
Earnings quality
What changed since the last call
Revenue growth guidance cut implicitly
DowngradePrior: 'double-digit growth expected.' Delivered: +4.6% YoY. No explicit new guidance, but acknowledge slowdown.
EBITDA margin halved vs prior year
DowngradeFY27 guidance 17-18% margin; Q2 delivered 7.62% (down from 15.2% YoY). Manpower costs blamed; price hikes lagging.
Subsidiary profitability pushed back
DowngradeAcemoney 'near breakeven' (not yet profitable); RVL early stage. Guidance for H2 FY27 profitability now uncertain.
Price hike strategy deployed
New12-15% price revision across majority of clients; implementation phased from Nov (banks) to Dec (others). Benefit accrual Q4 onwards.
The Q&A
Analysts (Keshav Garg, Dilip) pressed hard on margin math and profitability path. Management held up, acknowledging cost pressures and citing price hikes + tech cost cuts, but hedged on magnitude/timing. No formal concession of guidance miss, but defensive tone evident.
Margin collapse vs industry — Keshav Garg, Counter Cyclical PMS
AnsweredPricing is uniform across industry; manpower (drivers, gunmen, cash execs = 70% of cost) has spiked due to wage increases. We obtained 12-15% price hikes industry-wide; full benefit from Q4.
Shareholder wealth destruction — Rohan, ACMS
DodgedProfitability has been a concern, but worst is behind us. Price revisions, cost cuts, subsidiary turnarounds, improved RVL/Acemoney will restore IPO-level profitability gradually and rapidly.
Touch point growth slowdown — Krushi Parekh, BugleRock
AnsweredBank partnerships not growing as expected. Pivoting to direct clients (~20% of revenue now, targeting 33%). Hiring sector-specific executives to build direct client base in organized retail, NBFCs, hospitals.
Price hike realisation & wage pressure — Amit, Individual Investor
PartialMost hikes from banks only; retail slower. Gunman shortage acute in few states. No clear visibility on wage easing, but we've passed increases to clients. Second round of hikes unlikely unless macro deteriorates.
Profitability math post-hike — Dilip, Individual Investor
PartialAcemoney near breakeven. RVL 35% growth Q1-Q2. Both will contribute positively to PAT soon. Price increase + cost reduction (tech + hiring SMEs) will close gap. We're confident of restoration.
Election-period cash flow impact — Balakrishna, Individual Investor
AnsweredElections happened before with no material impact on cash movement. Clearances in place. No impact expected on volume handling.
Guidance
FY27 mid-teens growth expected (implicit from 'double-digit' prior)
LowQ2 delivered only +4.6% YoY. Full-year trajectory weak unless Q3-Q4 acceleration. Direct client push underway but not yet material.
FY27 standalone EBITDA 17-18% (contingent on price revision)
LowQ2 at 7.62%; price hikes lagging to Q4. Even with full benefit, path to 17-18% unclear without deeper cost cuts or higher price realization.
Profitability improvement from Q4 onwards via price hikes + cost reduction
MediumPrice hikes confirmed (12-15%, mostly by Dec). Tech-driven cost cuts unquantified. Subsidiary contribution timing uncertain.
No major capex expected; vans on lease
HighSubsidiary capex minimal (Acemoney sound boxes self-liquidating purchases). Capital-light model maintained.
Risks the call surfaced
Manpower cost inflation
HighMinimum wage increases (North/Central states particularly), guard shortage in southern states, driver and cash executive costs spiking. 70% of cost base affected.
Subsidiary turnaround execution
HighAcemoney 'near breakeven' (not yet profitable). RVL early-stage growth. Both still dragging consolidated PAT. Profitability promised for H2 but timeline uncertain.
Price hike realization risk
Medium12-15% price hikes secured but phased implementation (Nov for banks, Dec for retail). Benefit accrual delayed to Q4. Analyst Dilip challenged whether margin swing from -5% (current) to +20% (IPO level) is realistic even with hikes.
Bank partnership growth stalled
MediumBank-driven growth (80% of revenue) slowing; retail partnerships not expanding as expected. Direct client shift strategy unproven at scale (only 20% of revenue, slow growth from 15.7% YoY).
Profitability restoration credibility
HighMissed FY27 double-digit growth (delivered 4.6% YoY) and EBITDA 17-18% target (delivered 7.62%). Subsidiary profitability delayed. Management reaffirming confidence without quantified path to recovery.
Management
Score 6/10. Transparent on challenges (acknowledges profitability concern, cost spikes, guidance misses), but hedges on specifics. Reaffirms confidence without quantifying margin path or subsidiary turnaround timeline. Obtained price hikes (12-15% confirmed), lagging implementation (Q4). Missed Q2 guidance on revenue (+4.6% vs double-digit) and EBITDA (7.62% vs 17-18%). Subsidiary turnarounds delayed.
1 · Dec 2026
Price revision impact kicks in; majority of 12-15% hikes effective
2 · Q3 FY27
Acemoney expected to contribute positively to PAT; management targets profitability
3 · H2 FY27
Radiant Valuable Logistics and Acemoney both to turn profitable (management claim)
High execution risk.